The above findings validated the correlation between the Nrf2-ARE pathway and oxidative stress in vitiligo and its role in melanocyte destruction, opening the possibility of targeting the Nrf2-ARE pathway as a promising therapeutic strategy against melanocyte oxidative damage. The gene discussed is NFE2L2; the disease is vitiligo.